Patents Assigned to Millennium Pharmacueticals, Inc.
  • Boronic ester and acid compounds, synthesis and uses
    Patent number: 8378099
    Abstract: Disclosed herein is a method for reducing the rate of degradation of proteins in an animal, comprising contacting cells of the animal with certain boronic ester and acid compounds. Also disclosed herein are novel boronic ester and acid compounds, their synthesis and uses.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: February 19, 2013
    Assignee: Millennium Pharmacueticals, Inc.
    Inventors: Julian Adams, Ross L. Stein, Matthew Baevsky, Louis Grenier, Louis Plamondon
  • Anti-CCR2 antibodies and methods of use therefor
    Patent number: 6451522
    Abstract: The present invention relates to an antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 2 (CCR2) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the interaction of a cell bearing mammalian CCR2 with a ligand thereof, and to use of the antibodies and fragments in therapeutic, prophylactic and diagnostic methods.
    Type: Grant
    Filed: July 13, 2001
    Date of Patent: September 17, 2002
    Assignee: Millennium Pharmacueticals, Inc.
    Inventor: Gregory J. LaRosa